NCT05343234

Brief Summary

Each of the recruited patient was given 3 different placebo drugs with 3 different mad up names to be taken for one month with different regiments. The drug name resembled a real drug but with enough difference to prevent the patient from trying to buy it as a safety precaution. The name was printed on the box in English and Arabic letters. The coloured shape was printed to 2x2 cm dimension. After one month the participants were intervened by a doctor blinded to the study. The doctor asked about the drug history of the patient. If the participant could remember the drug name and its correct regiment the doctor documented that. if the patent failed to remember the correct name and its regiment then the doctor asked the patient to try and remember anything about the drug. Then the patient would be asked about the symbol on the drug and was it helpful for him in any way.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2022

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

April 17, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 25, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

April 25, 2022

Status Verified

April 1, 2022

Enrollment Period

2 months

First QC Date

April 17, 2022

Last Update Submit

April 22, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • score for remembering the drug name

    A scoring system was used to evaluate patients memory of the drugs name used 0- 3 0 is the minimal score and will be given if no recall of any drug name and 3 is the maximum score and will be given if the patient could remember the name of the tree drugs correctly.

    memory will be tested after one month from prescribing the drugs

  • score for remembering the drug symbol

    A scoring system was used to evaluate patients memory of the drugs symbol used 0- 3 0 is the minimal score and will be given if no recall of any drug symbol and 3 is the maximum score and will be given if the patient could remember the symbol of the tree drugs correctly.

    memory will be tested after one month from prescribing the drugs

Study Arms (1)

patients receiving the placebo medication

EXPERIMENTAL

tree different placebo drugs with tree different names and symbols one will be given twice daily one once in the morning one once before bedtime

Drug: Placebo

Interventions

tree different placebo drugs with tree different names and scheduled will be given

Also known as: placebo drugs
patients receiving the placebo medication

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA I and II patients

You may not qualify if:

  • severe or life-threatening condition
  • severe visual impairment
  • mental or cognitive dysfunction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alexandria university

Alexandria, 0203, Egypt

RECRUITING

Study Officials

  • yasser M osman

    Alexandria University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2022

First Posted

April 25, 2022

Study Start

April 1, 2022

Primary Completion

June 1, 2022

Study Completion

June 1, 2022

Last Updated

April 25, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations